Home > News > World
Monday August 25, 2014 MYT 11:45:03 AM
Monday August 25, 2014 MYT 11:46:18 AM
TOKYO (Reuters) - Japan could offer an unapproved drug under certain circumstances to help treat the deadly Ebola virus even before the World Health Organization has decided to make a request for the drug, the country's top government spokesman said on Monday.
Chief Cabinet Secretary Yoshihide Suga told a news conference that Japan would cooperate with the WHO and was ready to make an international contribution.
"I am informed that medical professionals could make a request for T-705 in an emergency even before a decision by the WHO. In that case, we would like to respond under certain criteria," he said.
T-705 is the developmental code for the influenza drug favipiravir. Japan's Fujifilm Holdings Corp and U.S. partner MediVector are in talks with the U.S. Food and Drug Administration to submit an application to expand the use of favipiravir as a treatment for Ebola.
The Ebola epidemic in West Africa has killed more than 1,000 people and prompted the WHO to declare an international health emergency.
(Reporting by Kaori Kaneko; Editing by Chris Gallagher)
Bomb near top Cairo court house kills two; other blasts hit capital
Obama hopes for U.S. embassy in Cuba before April summit in Panama
Video shows fatal Los Angeles police shooting of homeless man
U.S. spy chief says he got a mixed reception in North Korea
Malaysians abroad share how they celebrate our local festivals
8 Incredible food and wine adventures you can do in Australia!
Korea’s fabulous mountains
Australia were 'nervous' against New Zealand - Johnson
MWC2015: HTC's Triple treat
Copyright © 1995-2015 Star Publications (M) Bhd (Co No 10894-D)